End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
111,900
KRW
|
+0.72%
|
|
+2.57%
|
-10.84%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,512,246
|
4,633,750
|
2,488,073
|
1,478,007
|
1,432,354
|
1,277,135
|
-
|
-
|
Enterprise Value (EV)
2 |
1,820
|
4,890
|
2,808
|
1,948
|
1,432
|
1,894
|
1,839
|
1,932
|
P/E ratio
|
-415
x
|
57.2
x
|
20.2
x
|
22.6
x
|
-53.8
x
|
44.6
x
|
26.9
x
|
22.2
x
|
Yield
|
0.75%
|
0.37%
|
0.92%
|
1.54%
|
-
|
1.53%
|
1.53%
|
1.34%
|
Capitalization / Revenue
|
1.1
x
|
3.08
x
|
1.62
x
|
0.86
x
|
0.88
x
|
0.73
x
|
0.69
x
|
0.67
x
|
EV / Revenue
|
1.33
x
|
3.25
x
|
1.83
x
|
1.14
x
|
0.88
x
|
1.09
x
|
0.99
x
|
1.01
x
|
EV / EBITDA
|
22.8
x
|
49.4
x
|
21.7
x
|
13.3
x
|
13
x
|
14.2
x
|
11.5
x
|
11.9
x
|
EV / FCF
|
-20.9
x
|
-104
x
|
119
x
|
31.9
x
|
-
|
-7,576
x
|
33.4
x
|
48.3
x
|
FCF Yield
|
-4.79%
|
-0.96%
|
0.84%
|
3.14%
|
-
|
-0.01%
|
3%
|
2.07%
|
Price to Book
|
1.44
x
|
4.14
x
|
1.95
x
|
1.11
x
|
-
|
0.98
x
|
0.92
x
|
0.92
x
|
Nbr of stocks (in thousands)
|
11,413
|
11,413
|
11,413
|
11,413
|
11,413
|
11,413
|
-
|
-
|
Reference price
3 |
132,500
|
406,000
|
218,000
|
129,500
|
125,500
|
111,900
|
111,900
|
111,900
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/14/22
|
2/14/23
|
1/31/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,370
|
1,504
|
1,538
|
1,711
|
1,627
|
1,744
|
1,855
|
1,919
|
EBITDA
1 |
79.94
|
99.04
|
129.6
|
146.4
|
110.3
|
133.7
|
160
|
163
|
EBIT
1 |
40.26
|
50.25
|
73.66
|
81.26
|
34.44
|
62.77
|
88.77
|
100
|
Operating Margin
|
2.94%
|
3.34%
|
4.79%
|
4.75%
|
2.12%
|
3.6%
|
4.79%
|
5.21%
|
Earnings before Tax (EBT)
1 |
-6.142
|
104.5
|
172.6
|
85.73
|
-27.13
|
44.74
|
68.37
|
94
|
Net income
1 |
-3.638
|
89.27
|
136.9
|
65.45
|
-19.81
|
29.18
|
48.58
|
59
|
Net margin
|
-0.27%
|
5.94%
|
8.91%
|
3.82%
|
-1.22%
|
1.67%
|
2.62%
|
3.07%
|
EPS
2 |
-319.0
|
7,101
|
10,796
|
5,735
|
-2,333
|
2,507
|
4,158
|
5,035
|
Free Cash Flow
3 |
-87,163
|
-46,902
|
23,658
|
61,158
|
-
|
-250
|
55,140
|
40,000
|
FCF margin
|
-6,363.62%
|
-3,118.25%
|
1,538.39%
|
3,573.76%
|
-
|
-14.33%
|
2,973.23%
|
2,084.42%
|
FCF Conversion (EBITDA)
|
-
|
-
|
18,259.27%
|
41,786.24%
|
-
|
-
|
34,462.5%
|
24,539.88%
|
FCF Conversion (Net income)
|
-
|
-
|
17,274.74%
|
93,438.17%
|
-
|
-
|
113,495.72%
|
67,796.61%
|
Dividend per Share
2 |
1,000
|
1,500
|
2,000
|
2,000
|
-
|
1,708
|
1,708
|
1,500
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/14/22
|
2/14/23
|
1/31/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
465.7
|
402.3
|
416.9
|
423.2
|
459.7
|
411.5
|
349.5
|
432.9
|
439.4
|
404.9
|
374.8
|
461.9
|
479
|
428.8
|
378
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
29.6
|
42
|
39.8
|
13.8
|
-
|
EBIT
1 |
71.5
|
-13.94
|
41.8
|
13.1
|
48.8
|
-22.41
|
-13.6
|
23.7
|
32.8
|
-8.406
|
7.933
|
19
|
29.85
|
4.35
|
3
|
Operating Margin
|
15.35%
|
-3.46%
|
10.03%
|
3.1%
|
10.62%
|
-5.45%
|
-3.89%
|
5.47%
|
7.46%
|
-2.08%
|
2.12%
|
4.11%
|
6.23%
|
1.01%
|
0.79%
|
Earnings before Tax (EBT)
1 |
79.6
|
59.29
|
-
|
12.3
|
58.7
|
-17.61
|
-21
|
6.3
|
16.8
|
-29.25
|
-13.4
|
9
|
35
|
13
|
-1
|
Net income
1 |
53.7
|
65.45
|
-
|
12.9
|
37.5
|
8.621
|
-
|
1.8
|
13.9
|
-19.87
|
4.067
|
6.75
|
16.7
|
3.2
|
-1
|
Net margin
|
11.53%
|
16.27%
|
-
|
3.05%
|
8.16%
|
2.1%
|
-
|
0.42%
|
3.16%
|
-4.91%
|
1.09%
|
1.46%
|
3.49%
|
0.75%
|
-0.26%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/1/21
|
2/14/22
|
5/2/22
|
8/1/22
|
11/1/22
|
2/14/23
|
5/2/23
|
8/1/23
|
11/1/23
|
1/31/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
308
|
256
|
320
|
470
|
-
|
617
|
562
|
655
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.852
x
|
2.587
x
|
2.467
x
|
3.212
x
|
-
|
4.613
x
|
3.513
x
|
4.018
x
|
Free Cash Flow
2 |
-87,163
|
-46,902
|
23,658
|
61,158
|
-
|
-250
|
55,140
|
40,000
|
ROE (net income / shareholders' equity)
|
-0.35%
|
7.28%
|
9.89%
|
4.53%
|
-1.28%
|
2.58%
|
3.92%
|
4.3%
|
ROA (Net income/ Total Assets)
|
-0.2%
|
4.34%
|
5.34%
|
2.62%
|
-
|
1.25%
|
2.06%
|
2.6%
|
Assets
1 |
1,837
|
2,055
|
2,564
|
2,494
|
-
|
2,335
|
2,358
|
2,269
|
Book Value Per Share
3 |
91,888
|
98,003
|
111,693
|
116,370
|
-
|
114,195
|
121,085
|
122,084
|
Cash Flow per Share
|
3,530
|
3,152
|
11,038
|
10,440
|
-
|
-
|
-
|
-
|
Capex
1 |
127
|
82.9
|
102
|
58
|
-
|
57.4
|
76.5
|
-
|
Capex / Sales
|
9.31%
|
5.51%
|
6.65%
|
3.39%
|
-
|
3.29%
|
4.12%
|
-
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/14/22
|
2/14/23
|
1/31/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
111,900
KRW Average target price
144,667
KRW Spread / Average Target +29.28% Consensus |
1st Jan change
|
Capi.
|
---|
| -10.84% | 928M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|